HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

15.820

-0.190-1.19%

Volume:205.80K

Turnover:3.32M

Market Cap:5.13B

PE:-11.63

High:16.290

Open:15.800

Low:15.800

Close:16.010

52wk High:206.000

52wk Low:15.300

Shares:324.00M

HK Float Shares:153.00M

Volume Ratio:0.93

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.360

ROE:-31.30%

ROA:-10.95%

PB:3.04

PE(LYR):-11.63

PS:258.25

Loading ...

Overview Company News Filings

Visual Guide: BAO PHARMA-B (02659) Delivers 2026 Interim Results

BAO PHARMA-B (02659) Mid-Year Results: Narrowing Losses, Solid Cash Position, and a Premium Pipeline Reinforcing Long-Term Value

Shanghai Bao Pharma H1 FY26 Loss Narrows to RMB 153.69 Million; Revenue Drops 76.5% to RMB 9.88 Million

Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA

MT Newswires Live

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Bao Pharma secures U.S. FDA IND clearance for subcutaneous HER2 bispecific antibody KJ015

Bulletin Express

Shanghai Bao Pharmaceuticals Co - U.S. FDA Approves Ind for Kj015 for Injection on August 21, 2026

THOMSON REUTERS

Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results

Bulletin Express

Shanghai Bao Pharmaceuticals Schedules Board Meeting to Review Interim Results

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return Reporting Share Repurchase

BAO PHARMA-B (02659) Invests HKD 1.28 Million in Share Buyback on July 27

BAO PHARMA-B Spends HK$1.99 Million to Repurchase 115,200 Shares on July 24

Bao Pharma buys back 115,200 H-shares for HKD 1.99 million, trimming free float by 0.08%

Bulletin Express

Shanghai Bao Pharma Files HKEX Next-day Return Disclosing Share Repurchase at HKD 17.31 Each

Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million

Bulletin Express

Bao Pharma repurchases 110,900 H-shares; treasury stock climbs to 1.37 million

Bulletin Express

BAO PHARMA-B Repurchases 110.9 Thousand Shares for Approximately HK$2 Million on July 22

Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation

BAO PHARMA-B Allocates HK$1.99 Million for Share Buyback on July 20

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure on Share Repurchase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02659/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":15.82,"timestamp":1787904511835,"preClose":16.01,"halted":0,"volume":205800,"delay":0,"changeRate":-0.011867582760774594,"floatShares":153000000,"shares":324000000,"eps":-1.36,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"08-28 16:08:31","open":15.8,"high":16.29,"low":15.8,"amount":3317566,"amplitude":0.030606,"askPrice":16.19,"askSize":1100,"bidPrice":15.82,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-1.35,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":16.01,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0.930463875912999,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":153000000,"roa":"-10.95%","roe":"-31.30%","lyrEps":-1.36,"volumeRatio":0.930463875912999,"shares":324000000,"dividePrice":0,"high":16.29,"amplitude":0.030606,"preClose":16.01,"low":15.8,"week52Low":15.3,"pbRate":"3.04","psRate":"258.25","week52High":206,"institutionHeld":0,"latestPrice":15.82,"committee":-0.294118,"eps":-1.36,"divideRate":0,"volume":205800,"delay":0,"ttmEps":-1.35,"open":15.8,"prevYearClose":77.55,"prevWeekClose":16.09,"prevMonthClose":17.25,"prevQuarterClose":18,"fiveDayClose":16.09,"twentyDayClose":17.25,"sixtyDayClose":21.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-26","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1779984000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-08-28","current":-11.718519,"percent":0.994253,"low":-150.791275,"twenty":-75.047246,"median":-53.651638,"eighty":-12.841314,"high":-11.128507,"avg":-47.396445,"sd":35.818109,"marketCap":5157026776},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-20","current":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"marketCap":59426421069},{"date":"2026-02-27","current":-116.132786,"twenty":-104.714701,"median":-73.426035,"eighty":-56.395698,"marketCap":50494528928},{"date":"2026-03-06","current":-76.640212,"twenty":-111.983375,"median":-74.892856,"eighty":-56.998352,"marketCap":33054520551},{"date":"2026-03-13","current":-75.987902,"twenty":-110.582832,"median":-75.36732,"eighty":-57.563278,"marketCap":32924127965},{"date":"2026-03-20","current":-70.725897,"twenty":-109.509649,"median":-74.892856,"eighty":-57.733099,"marketCap":30528164197},{"date":"2026-03-27","current":-65.400661,"twenty":-104.714701,"median":-74.674242,"eighty":-58.326024,"marketCap":29273135557},{"date":"2026-04-02","current":-74.510382,"twenty":-96.653813,"median":-73.605533,"eighty":-59.04256,"marketCap":33510894602},{"date":"2026-04-10","current":-71.602503,"twenty":-91.308972,"median":-74.057958,"eighty":-59.568794,"marketCap":32451454840},{"date":"2026-04-17","current":-64.454748,"twenty":-86.399914,"median":-73.087213,"eighty":-60.479603,"marketCap":29224238337},{"date":"2026-04-24","current":-55.967849,"twenty":-84.718643,"median":-71.1642,"eighty":-60.173931,"marketCap":25377657050},{"date":"2026-04-30","current":-18.543355,"twenty":-83.426575,"median":-70.300184,"eighty":-58.506399,"marketCap":8410321797},{"date":"2026-05-08","current":-19.625214,"twenty":-81.092081,"median":-69.74185,"eighty":-56.760202,"marketCap":8931892141},{"date":"2026-05-15","current":-17.930681,"twenty":-79.944236,"median":-68.961959,"eighty":-55.831299,"marketCap":8182134771},{"date":"2026-05-22","current":-17.55647,"twenty":-79.579829,"median":-66.237091,"eighty":-53.674239,"marketCap":7993065521},{"date":"2026-05-29","current":-17.509903,"twenty":-78.962132,"median":-66.085797,"eighty":-51.516739,"marketCap":7999585151},{"date":"2026-06-05","current":-15.389804,"twenty":-78.220574,"median":-65.202887,"eighty":-19.743808,"marketCap":7041199644},{"date":"2026-06-12","current":-13.774642,"twenty":-77.936107,"median":-64.592987,"eighty":-19.178821,"marketCap":6297961903},{"date":"2026-06-18","current":-12.785133,"twenty":-77.726882,"median":-64.454748,"eighty":-18.7468,"marketCap":5857886926},{"date":"2026-06-26","current":-11.736313,"twenty":-77.358698,"median":-62.675612,"eighty":-18.25553,"marketCap":5352615655},{"date":"2026-07-03","current":-13.348826,"twenty":-77.285436,"median":-61.290684,"eighty":-17.828553,"marketCap":6092593580},{"date":"2026-07-10","current":-14.187594,"twenty":-77.122448,"median":-60.663453,"eighty":-17.509903,"marketCap":6467472265},{"date":"2026-07-17","current":-12.348746,"twenty":-76.777398,"median":-59.36056,"eighty":-15.389804,"marketCap":5649258788},{"date":"2026-07-24","current":-12.28898,"twenty":-76.640212,"median":-57.965274,"eighty":-14.102609,"marketCap":5623180271},{"date":"2026-07-31","current":-12.265678,"twenty":-76.228711,"median":-57.553252,"eighty":-13.925373,"marketCap":5623180271},{"date":"2026-08-07","current":-12.759971,"twenty":-76.015489,"median":-56.434485,"eighty":-13.758151,"marketCap":5861146740},{"date":"2026-08-14","current":-11.978357,"twenty":-75.491436,"median":-55.967849,"eighty":-13.50755,"marketCap":5509086758},{"date":"2026-08-21","current":-11.379099,"twenty":-75.31975,"median":-54.455852,"eighty":-13.139203,"marketCap":5245041771},{"date":"2026-08-28","current":-11.185615,"twenty":-75.047246,"median":-53.651638,"eighty":-12.841314,"marketCap":5157026776}],"updateTime":1788086773631},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134924940","title":"Visual Guide: BAO PHARMA-B (02659) Delivers 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1134924940","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134924940?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:32","pubTimestamp":1787913125,"startTime":"0","endTime":"0","summary":"A clear infographic breakdown of BAO PHARMA-B (02659) 2026 interim results is now available, highlighting key financial metrics and operational milestones for the period under review.The visual...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129257013","title":"BAO PHARMA-B (02659) Mid-Year Results: Narrowing Losses, Solid Cash Position, and a Premium Pipeline Reinforcing Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1129257013","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129257013?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:12","pubTimestamp":1787911954,"startTime":"0","endTime":"0","summary":"On August 28, BAO PHARMA-B (02659) released its interim results for the first half of 2026, posting a notable improvement in operational quality. The company's net loss narrowed significantly to RMB...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662582069","title":"Shanghai Bao Pharma H1 FY26 Loss Narrows to RMB 153.69 Million; Revenue Drops 76.5% to RMB 9.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662582069","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662582069?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911300,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma H1 FY26 loss narrows to RMB 153.69 million; revenue drops 76.5% to RMB 9.88 millionShanghai Bao Pharmaceuticals posted a net loss of RMB 153.69 million, narrowing from RMB 183.1 mi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLb4s9jW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627930","title":"Bao Pharmaceuticals' Trial Application for KJ015 for Injection Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627930","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627930?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575215,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals'  investigational new drug application for the clinical trials of KJ015 for injection was approved by the U.S. Food and Drug Administration.The injection is a subcutaneous formulation of dual epitope-targeting HER2 bispecific antibody, according to a Monday Hong Kong bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659","LABU","BK4588","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LABU","IBBQ","PSYK","BK1161","IBBJ","02659","BK4588","BK4585","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101074301","title":"Bao Pharma secures U.S. FDA IND clearance for subcutaneous HER2 bispecific antibody KJ015","url":"https://stock-news.laohu8.com/highlight/detail?id=1101074301","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101074301?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:06","pubTimestamp":1787565960,"startTime":"0","endTime":"0","summary":"On 21 August 2026, Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) received U.S. Food and Drug Administration clearance for an Investigational New Drug application covering KJ015 for Injection...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272972","title":"Shanghai Bao Pharmaceuticals Co - U.S. FDA Approves Ind for Kj015 for Injection on August 21, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272972?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:00","pubTimestamp":1787565636,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44J058:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171121109","title":"Shanghai Bao Pharma Sets 28 Aug 2026 Board Meeting to Review H1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1171121109","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171121109?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:48","pubTimestamp":1787042895,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. announced that its Board of Directors will convene on Friday, 28 August 2026. The meeting’s primary agenda is to review and approve the interim financial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468155","title":"Shanghai Bao Pharmaceuticals Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468155","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468155?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:32","pubTimestamp":1787041961,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals schedules board meeting to review interim resultsShanghai Bao Pharmaceuticals scheduled a board meeting for Aug. 28, 2026 to review interim results for the six months ende","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL1gqQTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008877","title":"Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return Reporting Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008877","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654008877?lang=en_us&edition=fundamental","pubTime":"2026-07-28 17:47","pubTimestamp":1785232021,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals files HKEX next-day disclosure return reporting share repurchaseShanghai Bao Pharmaceuticals repurchased 63,100 H shares on July 28, 2026 for treasury, no shares cancelled","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLbvRCKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172854354","title":"BAO PHARMA-B (02659) Invests HKD 1.28 Million in Share Buyback on July 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1172854354","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172854354?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:10","pubTimestamp":1785147014,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) announced that on July 27, 2026, it utilized HKD 1,284,900 to repurchase 70,600 of its own shares.\nThis move reflects the company's capital management strategy to return value to shareholders and signal confidence in its market position.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107205542","title":"BAO PHARMA-B Spends HK$1.99 Million to Repurchase 115,200 Shares on July 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1107205542","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107205542?lang=en_us&edition=fundamental","pubTime":"2026-07-26 09:50","pubTimestamp":1785030626,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on July 24, 2026, the company allocated approximately HK$1.9942 million to repurchase 115,200 of its own shares.The buyback operation involved the expenditure of HK$1,994,200 to acquire 115,200 shares of the company.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123845060","title":"Bao Pharma buys back 115,200 H-shares for HKD 1.99 million, trimming free float by 0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123845060","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123845060?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:06","pubTimestamp":1784887588,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share repurchase on 24 July 2026, acquiring 115,200 H-shares on the Hong Kong Stock Exchange. The shares were repurchased within a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653008334","title":"Shanghai Bao Pharma Files HKEX Next-day Return Disclosing Share Repurchase at HKD 17.31 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2653008334","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653008334?lang=en_us&edition=fundamental","pubTime":"2026-07-24 17:44","pubTimestamp":1784886268,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day return disclosing share repurchase at HKD 17.31 eachShanghai Bao Pharmaceuticals repurchased 115,200 H shares on July 24 for treasury, not cancellation.Buyback ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL7LCQGm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155446130","title":"Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1155446130","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155446130?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:02","pubTimestamp":1784800956,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137706624","title":"Bao Pharma repurchases 110,900 H-shares; treasury stock climbs to 1.37 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1137706624","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137706624?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:21","pubTimestamp":1784715661,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) reported the repurchase of 110,900 H-shares on 22 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The buyback was executed at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120263897","title":"BAO PHARMA-B Repurchases 110.9 Thousand Shares for Approximately HK$2 Million on July 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1120263897","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120263897?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:50","pubTimestamp":1784713824,"startTime":"0","endTime":"0","summary":"On July 22, BAO PHARMA-B (02659) executed a share buyback transaction. The company repurchased a total of 110.9 thousand shares of its own stock, utilizing approximately HK$1.9955 million in capital for the transaction.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653756623","title":"Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653756623","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653756623?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:45","pubTimestamp":1784713550,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share repurchase for cancellationShanghai Bao Pharmaceuticals repurchased 110,900 H shares on July 22 for treasury, no cancellations.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL4g5rVw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174886086","title":"BAO PHARMA-B Allocates HK$1.99 Million for Share Buyback on July 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1174886086","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174886086?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:40","pubTimestamp":1784544020,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced the execution of a share repurchase, according to a company filing.The transaction, conducted on July 20, 2026, involved a total expenditure of HK$1,994,700.This...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652927402","title":"Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure on Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2652927402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652927402?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:35","pubTimestamp":1784543712,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals files HKEX next-day disclosure on share repurchaseShanghai Bao Pharmaceuticals repurchased 112,200 H shares on July 20, 2026 for treasury, with no shares bought back for c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL19bPTc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":126,"code":"91000000","status":"200"}]}}